PharmaShots | Incisive News in 3 Shots

Subscribe Now

the EC

Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

August 21, 2020

Celltrion's Remsima SC (infliximab- CT-P13) Receives the EC's MAA for Additional Five Indications

Celltrion's Remsima SC (infliximab- CT-P13) Receives the EC's MAA for Additional Five Indications

July 27, 2020

Novartis' Enerzair Breezhaler Receives the EC's Approval as a Maintenance Treatment of Asthma in Adult Patients Uncontrolled with LABA/ICS

Novartis' Enerzair Breezhaler Receives the EC's Approval as a Maintenance Treatment of Asthma in Adult Patients Uncontrolled with...

July 7, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us